Quince Therapeutics, Inc. - QNCX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | CEO and CMO | A | A | 1,000,000.0 | 0.0 | 0.0 | 1,000,000.0 | View | |
| Jan 23, 2026 | President | A | A | 200,000.0 | 0.0 | 0.0 | 200,000.0 | View | |
| Jan 23, 2026 | CBO, COO & CCO | A | D | 365,000.0 | 0.0 | 0.0 | 365,000.0 | View | |
| Jan 21, 2026 | — | A | A | 21,810.0 | 0.0 | 0.0 | 21,810.0 | View | |
| Jan 21, 2026 | — | A | A | 19,547.0 | 0.0 | 0.0 | 19,547.0 | View | |
| Jan 21, 2026 | — | A | A | 29,423.0 | 0.0 | 0.0 | 29,423.0 | View | |
| Jan 21, 2026 | — | A | A | 18,724.0 | 0.0 | 0.0 | 18,724.0 | View | |
| Dec 29, 2025 | — | S | D | 50,000.0 | 3.47 | 173,500.0 | 39,179.0 | View | |
| Dec 29, 2025 | — | J | A | 8,918.0 | — | — | 89,179.0 | View | |
| Dec 12, 2025 | CEO and CMO | G | A | 739,885.0 | 0.0 | 0.0 | 739,885.0 | View | |
| Dec 12, 2025 | CEO and CMO | G | D | 739,885.0 | 0.0 | 0.0 | 255,000.0 | View | |
| Dec 08, 2025 | CBO, COO & CCO | M | D | 25,280.0 | 0.0 | 0.0 | 199,720.0 | View | |
| Dec 08, 2025 | CBO, COO & CCO | M | D | 2,271.0 | 0.0 | 0.0 | 45,168.0 | View | |
| Dec 08, 2025 | CBO, COO & CCO | M | A | 25,280.0 | 0.94 | 23,763.2 | 361,827.0 | View | |
| Dec 08, 2025 | CBO, COO & CCO | M | A | 2,271.0 | 0.55 | 1,249.05 | 336,547.0 | View |